New Psychoactive Substances, Edition 6

In 2017, 51 new compounds were reported to the EMCDDA for the first time, bringing the total number of substances monitored to more than 670. Following a high of 101 substances notified in 2014, the number has decreased. Whilst this is a positive trend, the concerning development in the market has been the significant increase in the availability of new synthetic opioids. A total of 38 have been reported with highly potent fentanils (n=28) dominating. 

 

Chiron work closely with clinical and forensic institutions to proactively meet demand for NPS reference materials. Edition 6 of our NPS catalogue showcases our impressive range of available standards in this field. We now also provide mixes of NPS as well as custom made solutions.

 

Click here to view our catalogue

Share
Chiron AS, Stiklestadveien 1, NO-7041 Trondheim, Norway T: +47 73 87 44 90 F: +47 73 87 44 99 E: sales@chiron.no Contact us